Amer Samad serves as Executive at NEUROONE MEDICAL TECHNOLOGIES Corp, where they oversee executive responsibilities. Since joining the company, Amer Samad has executed 2 insider transactions totaling $472, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 20, 2017 involved transacting 3,500,000 shares valued at $0.
Amer Samad currently holds 15,728 shares of NEUROONE MEDICAL TECHNOLOGIES Corp (OSOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amer Samad has been a net buyer of OSOK stock. They have purchased $472 and sold $0 worth of shares.
Amer Samad's most recent insider trade was on Jul 20, 2017, when they sold 3,500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.03 |
| Discretionary |